
Pacira BioSciences Investor Relations Material
Latest events

Q1 2025
Pacira BioSciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Pacira BioSciences Inc
Access all reports
Pacira BioSciences Inc. is a pharmaceutical company focused on developing and commercializing non-opioid pain management and regenerative health solutions. The company's primary offerings include products designed to provide long-lasting pain relief for patients undergoing surgical procedures. Pacira BioSciences serves the healthcare sector, working with hospitals, ambulatory surgery centers, and healthcare providers to reduce reliance on opioids and improve patient outcomes through its innovative treatments. The company is headquartered in Tampa, Florida, and its shares are listed on the NASDAQ.
Key slides for Pacira BioSciences Inc


Q2 2024
Pacira BioSciences Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Pacira BioSciences Inc
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
PCRX
Country
🇺🇸 United States